Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of adamantyl-derived, inhaled, long acting beta(2)-adrenoreceptor agonistsAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.Bioorganic & Medicinal Chemistry Letters|May 15, 2007
The discovery of long acting beta2-adrenoreceptor agonistsAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activityPatrick Dorr, Mike Westby, Susan Dobbs, et al.Therapeutic Advances in Medical Oncology|March 5, 2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitorsRobert Hsu, Karen Resnick, Peter Zang, et al.Cell Reports|January 4, 2018
Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding ModeFelix Weber, Bernd Bohrmann, Jens Niewoehner, et al.Antimicrobial Agents and Chemotherapy|December 29, 2011
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapyHelen Lavender, Kevin Brady, Frances Burden, et al.Diabetes Research and Clinical Practice|March 21, 2025
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetesTadej Battelino, Nebojsa Lalic, Sufyan Hussain, et al.Journal of Investigative Medicine High Impact Case Reports|March 22, 2021
Incidental Finding of a Large Right Atrial Thrombus in a Patient With Cerebral LymphomaAyman R Fath, Abdullah S Eldaly, Amro Aglan, et al.Mabs|October 12, 2023
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humansHans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.Pageof 6